APOE and Alzheimer disease: In this respect, ApoA-I may have actions analogous to apolipoprotein E (ApoE) where common genetic variants have directly opposing effects on β-amyloid deposition and clearance and therefore risk for Alzheimer’s disease (Corder et al., 1993).